Mode
Text Size
Log in / Sign up
N/A N=132 Randomized Prevention

Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi

HIV Prevention

Enrolled (actual)
132
Serious AEs
0.8%
Results posted
Dec 2025
Primary outcome: Primary: Mean Acceptability of Intervention (AIM) Scale Score — 4.65; 4.52 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Behavioral: My Choice for HIV Prevention (MyChoice) (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of North Carolina, Chapel Hill
Primary completion
Feb 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Acceptability of Intervention (AIM) Scale Score
4.65; 4.52
PRIMARY
Mean Intervention Appropriateness Measure (IAM) Scale Score
4.59; 4.46
PRIMARY
Mean Feasibility Intervention Measure (FIM) Scale Score
4.53
SECONDARY
Mean Decisional Conflict Scale (DCS) Score
14.8; 18.3 0.2157

Summary

Purpose: The overall objective of this pilot study is to evaluate the feasibility, acceptability, and appropriateness of a shared decision-making (SDM) intervention to support personally appropriate decision making about PrEP use during pregnancy and breastfeeding. Participants: The primary population to be recruited for this study is HIV-negative pregnant women. For qualitative data collection only, investigators will also recruit male partners of these participants, and PrEP counselors and health care workers. 100 HIV-negative pregnant women will be recruited to participate in the pilot study. A subset of these participants will participate in qualitative interviews. Up to 20 male partners and up to 15 study staff will be recruited to participate in qualitative in-depth interviews. Procedures (methods): 100 women will be randomized to receive either the SDM intervention addressing daily oral PrEP and alternative HIV prevention methods (condoms), or standard of care counselling addressing the same prevention methods. Investigators will evaluate the feasibility, acceptability, and appropriateness of the intervention and associated study procedures. Women expressing interest in oral PrEP will be referred to government PrEP services.

Eligibility Criteria

The criteria for pregnant women participants is as follows:

Inclusion Criteria

  • Age 18 or older
  • Documented pregnancy by urine pregnancy test or physical exam
  • Documented negative HIV status within the past three months
  • Identified factor(s) for elevated risk for HIV acquisition per PrEP national eligibility guidelines
  • Willingness to remain in the study site's catchment area over the course of study follow-up and to comply with visit schedule
  • Ability and willingness to provide informed consent

Exclusion Criteria

  • Positive HIV test at time of screening
  • No identified HIV risk factors per national PrEP guidelines
  • Risk for intimate partner violence or social harms as a result of participation, in the judgement of the study personnel

Investigators will also conduct interviews with male partners and study staff to assess exploratory qualitative outcomes. All study staff will be eligible to participate in an interview. Male partners will be eligible to participate if they meet the following criteria:

  • Referred by a study participant as her romantic partner
  • Age 18 or older
  • Able and willing to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06394323). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search